Back
Day Range
$27.46
$28.65
52-Week Range
$22.24
$46.00
Volume
750,001
50D / 200D Avg
$28.20
/
$33.93
Prev Close
$28.11
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -4.0 | 0.3 |
| P/B | 1.4 | 2.9 |
| ROE % | -30.2 | 3.7 |
| Net Margin % | -764.0 | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
Hold
$41.50
+46.4%
Low: $25.00
High: $62.00
Forward EPS
-$6.63
Est. Revenue
91 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
-$0.06
-$0.09 – -$0.04
|
670 M | 6 |
| FY2029 |
-$2.35
-$3.33 – -$1.35
|
500 M | 6 |
| FY2028 |
-$3.42
-$5.01 – -$1.10
|
370 M | 8 |
Key Takeaways
Earnings declined -161.27% over the past year
Debt/Equity of 0.05 — conservative balance sheet
Negative free cash flow of -377.29M
PEG of 0.02 suggests growth is underpriced
Capital efficient — spends only 7.99% of revenue on capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)48.03%
Earnings (1Y)-161.27%
FCF Growth (3Y)N/A
Quality
Return on Equity
-30.20%
ROIC-28.21%
Net Margin-764.01%
Op. Margin-873.87%
Safety
Debt / Equity
0.05
Current Ratio11.46
Interest Coverage0.00
Valuation
P/E Ratio
-4.02
P/B Ratio1.39
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 48.03% | Revenue Growth (3Y) | 41.92% |
| Earnings Growth (1Y) | -161.27% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 54.03M | Net Income (TTM) | -412.78M |
| ROE | -30.20% | ROA | -31.82% |
| Gross Margin | 88.26% | Operating Margin | -873.87% |
| Net Margin | -764.01% | Free Cash Flow (TTM) | -377.29M |
| ROIC | -28.21% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.05 | Current Ratio | 11.46 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -4.02 | P/B Ratio | 1.39 |
| P/S Ratio | 30.74 | PEG Ratio | 0.02 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.66B | Enterprise Value | 1.63B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 54.03M | 36.50M | 26.82M | 14.24M | 0.0 |
| Net Income | -412.78M | 673.73M | -352.09M | -231.80M | 1.60B |
| EPS (Diluted) | -7.12 | 11.64 | -6.33 | -4.23 | -6.36 |
| Gross Profit | 47.68M | 32.33M | 17.32M | 12.54M | -18.78M |
| Operating Income | -472.13M | -425.74M | -391.49M | -389.05M | -378.42M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.30B | 1.66B | 937.12M | 1.24B | 1.44B |
| Total Liabilities | 104.11M | 122.24M | 126.10M | 137.90M | 145.76M |
| Shareholders' Equity | 1.19B | 1.54B | 811.02M | 1.10B | 1.29B |
| Total Debt | 62.02M | 56.99M | 72.00M | 85.66M | 97.09M |
| Cash & Equivalents | 89.13M | 76.25M | 88.21M | 139.26M | 203.13M |
| Current Assets | 942.05M | 965.60M | 833.84M | 832.77M | 1.06B |
| Current Liabilities | 82.21M | 81.16M | 67.96M | 62.63M | 59.83M |